Williams v. Janssen Research & Development, LLC
| Otis Williams, Sr. |
| JANSSEN ORTHO LLC, MITSUBISHI TANABE PHARMA CORP., JOHNSON & JOHNSON, Tanabe Research Laboratories U.S.A., Inc., Mitsubishi Tanabe Pharma Holding America, Inc., JANSSEN RESEARCH & DEVELOPMENT LLC, JANSSEN PHARMACEUTICALS INC and Mitsubishi Tanabe Pharma Development America, Inc. |
| INVOKANA (CANAGLIFLOZIN) PRODUCTS LIABILITY LITIGATION |
| 3:2019cv18546 |
| September 30, 2019 |
| US District Court for the District of New Jersey |
| Lois H Goodman |
| Brian R Martinotti |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 30, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 Certified Copy of Transfer Order and docket received, Case transferred in from District of Louisiana Middle; Case Number 3:19-cv-00608. Original file certified copy of transfer order and docket sheet received. |
Filing 11
Order Transferring Case to JPML Court. (Attachments: #1 Attachment)(ELW)
|
|
Filing 10
ORDER granting #8 Motion for Extension of Time to Answer #1 Notice of Removal. The removing Defendants are allowed an additional extension of time up to, through and until twenty-one (21) days after the case is transferred to the MDL or the JPML issues a decision granting a motion to vacate the conditional transfer order covering this action or otherwise finally denying transfer of this action to the MDL. Signed by Magistrate Judge Richard L. Bourgeois, Jr. on 9/27/2019. (EDC)
|
| Filing 9 Initial Conditional Transfer Order from the JPML Panel (Attachments: #1 Attachment) (ELW) |
| MOTION(S) REFERRED: #8 Consent MOTION for Extension of Time to File Answer to #1 Notice of Removal, or Otherwise File Responsive Pleadings. This motion is now pending before the USMJ. (LT) |
| Filing 8 Consent MOTION for Extension of Time to File Answer to #1 Notice of Removal, or Otherwise File Responsive Pleadings by Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, Mitsubishi Tanabe Pharma Development America, Inc., Tanabe Research Laboratories U.S.A., Inc.. (Attachments: #1 Proposed Order)(Rookard, Kelly) |
| Filing 7 NOTICE of Compliance by Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, Mitsubishi Tanabe Pharma Development America, Inc., Tanabe Research Laboratories U.S.A., Inc. with 28 U.S.C. 1447(b) (Attachments: #1 Ex. A: State Court Pleadings)(Rookard, Kelly) |
|
Filing 6
ORDER granting #5 MOTION to Substitute Record Document No. 1. The Clerk's Office is instructed to substitute R. Doc. 5-1 in the place of R. Doc. 1. Signed by Magistrate Judge Richard L. Bourgeois, Jr. on 9/16/2019. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.) (SGO)
|
| Filing 5 MOTION to Substitute Notice of Removal (to correct caption) by Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, Mitsubishi Tanabe Pharma Development America, Inc., Tanabe Research Laboratories U.S.A., Inc.. (Attachments: #1 Notice of Removal with corrected caption, #2 Proposed Order)(Rookard, Kelly) |
| MOTION(S) REFERRED: #5 MOTION to Substitute Notice of Removal (to correct caption) . This motion is now pending before the USMJ. (LT) |
| Filing 4 Letter to JPML Panel notifying panel of possible JPML case (KMW) |
| Filing 3 Letter to Attorney Keelus Miles regarding Skyler Williams who is Co-Counsel for party Otis Williams, Sr.. Attorney is not admitted to practice in LAMD. (KMW) |
| Filing 2 Corporate Disclosure Statement by Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, Mitsubishi Tanabe Pharma Development America, Inc., Tanabe Research Laboratories U.S.A., Inc. identifying Corporate Parent Mitsubishi Tanabe Pharma Holdings America, Inc., Other Affiliate Mitsubishi Chemical Holdings Corporation for Mitsubishi Tanabe Pharma Development America, Inc., Tanabe Research Laboratories U.S.A., Inc. ; Other Affiliate OMJ PR Holdings for Janssen Ortho LLC; Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc.; Other Affiliate Centocor Research & Development, Inc. for Janssen Research & Development, LLC.. (Rookard, Kelly) |
| Filing 1 NOTICE OF REMOVAL from 23rd JDC, Parish of Ascension, Case Number 125308. (Filing fee $ 400 receipt number ALAMDC-2000416), filed by Mitsubishi Tanabe Pharma Development America, Inc., Johnson & Johnson, Tanabe Research Laboratories U.S.A., Inc., Janssen Research & Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc.. (Attachments: #1 Civil Cover Sheet, #2 Ex. A: Petition for Damages)(Rookard, Kelly) (Main Document 1 replaced on 9/17/2019) (ELW). Modified on 9/17/2019 as ordered by rec doc 6 (ELW). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
